Chargement en cours...
PIGMENTED BASAL CELL CARCINOMA SUCCESSFULLY TREATED WITH 5% IMIQUIMOD CREAM
Basal cell carcinoma (BCC) is the most common malignant skin tumor, amongst which the nodular, nodulo ulcerative and superficial types comprise nearly 80% of all BCCs. Topical Imiquimod, an immune response modifier has been found to be effective in superficial and nodular types of BCC with histologi...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Medknow Publications
2008
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2763750/ https://ncbi.nlm.nih.gov/pubmed/19882014 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0019-5154.43204 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|